VRTX

Q: What is the price of Vertex Pharmaceuticals (VRTX) today?

The price of Vertex Pharmaceuticals (VRTX) today is $ 424.00, with return of -8.17% compared to the last year. The price of Vertex Pharmaceuticals (VRTX) started the year trading around $ 402.70 and today it is at $ 424.00. Follow the real-time price chart, the historical price of Vertex Pharmaceuticals (VRTX) and international markets.

Q: When does Vertex Pharmaceuticals (VRTX) pay dividends?

Vertex Pharmaceuticals (VRTX) did not distribute dividends in the last year.

Q: Is Vertex Pharmaceuticals (VRTX) worth it?

Currently, Vertex Pharmaceuticals (VRTX) is priced at $ 424.00, with a P/E of 29.73%, representando um desvio de -1,719% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of -8.17 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -8.17%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Vertex Pharmaceuticals (VRTX) stock?

Investing in stocks of Vertex Pharmaceuticals (VRTX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Vertex Pharmaceuticals (VRTX) yield today?

The yield of Vertex Pharmaceuticals (VRTX) was 0.62% in the last month, -8.17% in the last year and 87.02% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Vertex Pharmaceuticals (VRTX) today, the total investment would be $ 42,400.00, based on the current price of $ 424.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 38,935.92In 5 years: $ 79,296.48In 10 years: $ 138,974.48It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Vertex Pharmaceuticals Incorporated

Price

$ 424.00

return (12m)

-8.17%

p/e

29.73

p/bv

6.31

DIVIDEND YIELD

0.00%

price VRTX

BVMF

VRTX

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, you would now have

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of VRTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.62%

3 months

8.98%

1 year

-8.17%

2 years

21.08%

5 years

87.02%

10 years

227.77%

Fundamentals VRTX

review the fundamentals of Vertex Pharmaceuticals shares

P/E

29.73

Sector: -3.40 Industry: -3.40

P/SALES RATIO (PSR)

9.32

Sector: -3.36 Industry: -3.36

P/BV

6.31

Sector: 1.98 Industry: 1.98

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

14.78%

Sector: -62.78% Industry: -62.78%

ROE

21.22%

Sector: -68.26% Industry: -68.26%

ROIC

28.72%

Sector: -1,140.39% Industry: -1,140.39%

NET MARGIN

31.35%

Sector: -41.80% Industry: -41.80%

GROSS MARGIN

86.28%

Sector: 39.33% Industry: 39.33%

OPERATING MARGIN

38.70%

Sector: -41.58% Industry: -41.58%

P/EBITDA

23.70

Sector: -3.48 Industry: -3.48

P/EBIT

24.49

Sector: -3.60 Industry: -3.60

P/ASSET

4.39

Sector: 1.42 Industry: 1.42

BVPS

67.65

Sector: 1.79 Industry: 1.79

EPS

14.36

Sector: -2.05 Industry: -2.05

EQUITY RATIO

0.70

Sector: 0.42 Industry: 0.42

CAGR REVENUE 5 YEARS

13.57%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

6.27%

Sector: - Industry: -

FAIR VALUE OF Vertex Pharmaceuticals ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

$ 424.00

Fair Value

$ 0.00

Upside Return potential.

-65.13%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals VRTX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	19.42	0.00	0.00%	2.51%	$ 487.73 B	27.26%
PFE	14.23	1.50	10.56%	6.95%	$ 139.89 B	15.65%
ABBV	102.44	-2,793.44	-2,726.81%	2.97%	$ 385.49 B	6.45%
NVO	13.73	7.92	57.70%	3.54%	$ 211.67 B	32.78%
MRK	12.83	0.00	0.00%	3.31%	$ 244.20 B	29.63%
AZN	30.03	6.14	20.45%	1.72%	$ 282.28 B	16.17%
BMY	15.59	5.06	32.47%	5.36%	$ 94.17 B	12.57%
GILD	19.41	7.34	37.80%	2.48%	$ 157.41 B	27.88%
ZTS	20.40	10.02	49.11%	1.58%	$ 54.07 B	28.21%
HALO	13.82	16.33	118.17%	0.00%	$ 8.23 B	47.91%
REGN	17.17	2.54	14.79%	0.35%	$ 78.61 B	32.13%
AMGN	25.92	18.88	72.82%	2.78%	$ 181.60 B	19.47%
MCK	26.63	-185.79	-697.75%	0.34%	$ 107.39 B	1.04%
ADMA	19.60	9.52	48.57%	0.00%	$ 4.11 B	42.87%
CAH	31.26	-18.26	-58.40%	0.97%	$ 49.86 B	0.68%
BIIB	16.02	1.42	8.83%	0.00%	$ 25.77 B	15.98%
HRMY	10.72	2.38	22.24%	0.00%	$ 1.99 B	22.48%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

VRTX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated

Average user rating I10

5.0 (17 people)

United States

36 years

Founded: 1989

1991

Time since IPO - 34 years

3.400

Employees

The Company Vertex Pharmaceuticals Incorporated (United States), is listed on Nasdaq with a market cap of $ 109.25 Billions, having an equity of $ 17.32 Billions.

With a total of 3.400 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 11.72 Billions, which generated a profit in the amount of $ 3.68 Billions.

As for its main indicators, the Company has a P/E ratio of 29.73, a P/BV ratio of 6.31 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker VRTX.

Market cap

$ 109.25 Billions

Equity

$ 17.32 Billions

US$ 17,318,800,000.00

Assets

$ 24.86 Billions

US$ 24,862,300,000.00

Total Shares Outstanding

256.00 Millions

256,000,000

Average Daily Trading Volume

$ 1.53 Million

US$ 1,529,540.26

Sector

Health Care

Industry

Biotechnology

VRTX

VRTX revenue and profits

Financial Results VRTX

DRAG THE FRAME TO SEE MORE DATA

VRTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 870.21 41,86% (12M)

P/E

26.63

0.34%

ROE

-697.75%

P/BV

-185.79

CAH - Cardinal Health

$ 211.20 76,36% (12M)

P/E

31.26

0.97%

ROE

-58.40%

P/BV

-18.26

JNJ - Johnson & Johnson

$ 206.05 37,46% (12M)

P/E

19.42

2.51%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 100.40 3,83% (12M)

P/E

12.83

3.31%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.22 6,38% (12M)

P/E

14.23

6.95%

ROE

10.56%

P/BV

1.50

ABBV - AbbVie

$ 229.51 34,15% (12M)

P/E

102.44

2.97%

ROE

-2,726.81%

P/BV

-2,793.44

AZN - AstraZeneca

$ 91.52 40,77% (12M)

P/E

30.03

1.72%

ROE

20.45%

P/BV

6.14

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 870.21 41,86% (12 M)

P/L

26.63

0.34%

ROE

-697.75%

P/VP

-185.79

CAH - Cardinal Health

$ 211.20 76,36% (12 M)

P/L

31.26

0.97%

ROE

-58.40%

P/VP

-18.26

JNJ - Johnson & Johnson

$ 206.05 37,46% (12 M)

P/L

19.42

2.51%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 100.40 3,83% (12 M)

P/L

12.83

3.31%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.22 6,38% (12 M)

P/L

14.23

6.95%

ROE

10.56%

P/VP

1.50

ABBV - AbbVie

$ 229.51 34,15% (12 M)

P/L

102.44

2.97%

ROE

-2,726.81%

P/VP

-2,793.44

AZN - AstraZeneca

$ 91.52 40,77% (12 M)

P/L

30.03

1.72%

ROE

20.45%

P/VP

6.14

Frequently Asked Questions

What is the price of Vertex Pharmaceuticals (VRTX) today?

The price of Vertex Pharmaceuticals (VRTX) today is $ 424.00, with return of -8.17% compared to the last year. The price of Vertex Pharmaceuticals (VRTX) started the year trading around $ 402.70 and today it is at $ 424.00. Follow the real-time price chart, the historical price of Vertex Pharmaceuticals (VRTX) and international markets.

When does Vertex Pharmaceuticals (VRTX) pay dividends?

Vertex Pharmaceuticals (VRTX) did not distribute dividends in the last year.

Is Vertex Pharmaceuticals (VRTX) worth it?

Currently, Vertex Pharmaceuticals (VRTX) is priced at $ 424.00, with a P/E of 29.73%, representando um desvio de -1,719% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of -8.17 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was -8.17%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Vertex Pharmaceuticals (VRTX) stock?

Investing in stocks of Vertex Pharmaceuticals (VRTX) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Vertex Pharmaceuticals (VRTX) yield today?

The yield of Vertex Pharmaceuticals (VRTX) was 0.62% in the last month, -8.17% in the last year and 87.02% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Vertex Pharmaceuticals (VRTX) today, the total investment would be $ 42,400.00, based on the current price of $ 424.00.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 38,935.92
In 5 years: $ 79,296.48
In 10 years: $ 138,974.48

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

VRTX

Vertex Pharmaceuticals Incorporated

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of VRTX

review the fundamentals of Vertex Pharmaceuticals shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated

United States

36 years

1991

3.400

PROFIT X PRICE VRTX

Financial Results VRTX

VRTX cash flow

asset growth - VRTX

VRTX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions